210 related articles for article (PubMed ID: 24372050)
1. Classification SAR modeling of diverse quinolone compounds for antimalarial potency against Plasmodium falciparum.
Aher RB; Roy K
Comb Chem High Throughput Screen; 2014; 17(5):396-406. PubMed ID: 24372050
[TBL] [Abstract][Full Text] [Related]
2. Understanding the structural requirements in diverse scaffolds for the inhibition of P. falciparum dihydroorotate dehydrogenase (PfDHODH) using 2D-QSAR, 3D-pharmacophore and structure-based energy- optimized pharmacophore models.
Aher RB; Roy K
Comb Chem High Throughput Screen; 2015; 18(2):217-26. PubMed ID: 25543684
[TBL] [Abstract][Full Text] [Related]
3. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
Kumari M; Chandra S; Tiwari N; Subbarao N
BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
[TBL] [Abstract][Full Text] [Related]
4. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
5. Pharmacophore modeling of substituted 1,2,4-Trioxanes for quantitative prediction of their antimalarial activity.
Gupta AK; Chakroborty S; Srivastava K; Puri SK; Saxena AK
J Chem Inf Model; 2010 Aug; 50(8):1510-20. PubMed ID: 20726605
[TBL] [Abstract][Full Text] [Related]
6. QSAR and pharmacophore modeling of natural and synthetic antimalarial prodiginines.
Singh B; Vishwakarma RA; Bharate SB
Curr Comput Aided Drug Des; 2013 Sep; 9(3):350-9. PubMed ID: 24010933
[TBL] [Abstract][Full Text] [Related]
7. Design of antimalarial transmission blocking agents: Pharmacophore mapping of ligands active against stage-V mature gametocytes of
Aher RB; Roy K
J Biomol Struct Dyn; 2019 Sep; 37(14):3660-3673. PubMed ID: 30238847
[TBL] [Abstract][Full Text] [Related]
8. Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria.
Biagini GA; Fisher N; Shone AE; Mubaraki MA; Srivastava A; Hill A; Antoine T; Warman AJ; Davies J; Pidathala C; Amewu RK; Leung SC; Sharma R; Gibbons P; Hong DW; Pacorel B; Lawrenson AS; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Stocks PA; Nixon GL; Chadwick J; Hemingway J; Delves MJ; Sinden RE; Zeeman AM; Kocken CH; Berry NG; O'Neill PM; Ward SA
Proc Natl Acad Sci U S A; 2012 May; 109(21):8298-303. PubMed ID: 22566611
[TBL] [Abstract][Full Text] [Related]
9. Role of Trifluoromethyl Substitution in Design of Antimalarial Quinolones: a Comprehensive Review.
Romero AH
Top Curr Chem (Cham); 2019 Mar; 377(2):9. PubMed ID: 30835005
[TBL] [Abstract][Full Text] [Related]
10. Exploring the structural requirements in multiple chemical scaffolds for the selective inhibition of Plasmodium falciparum calcium-dependent protein kinase-1 (PfCDPK-1) by 3D-pharmacophore modelling, and docking studies.
Aher RB; Roy K
SAR QSAR Environ Res; 2017 May; 28(5):390-414. PubMed ID: 28562086
[TBL] [Abstract][Full Text] [Related]
11. Drug discovery studies on quinoline-based derivatives as potential antimalarial agents.
Sharma R; Patil S; Maurya P
SAR QSAR Environ Res; 2014; 25(3):189-203. PubMed ID: 24601770
[TBL] [Abstract][Full Text] [Related]
12. Exploring structural requirements for a class of nucleoside inhibitors (PfdUTPase) as antimalarials: first report on QSAR, pharmacophore mapping and multiple docking studies.
Ojha PK; Roy K
Comb Chem High Throughput Screen; 2013 Nov; 16(9):739-57. PubMed ID: 23701009
[TBL] [Abstract][Full Text] [Related]
13. Identification of new antimalarial drugs by linear discriminant analysis and topological virtual screening.
Mahmoudi N; de Julián-Ortiz JV; Ciceron L; Gálvez J; Mazier D; Danis M; Derouin F; García-Domenech R
J Antimicrob Chemother; 2006 Mar; 57(3):489-97. PubMed ID: 16415127
[TBL] [Abstract][Full Text] [Related]
14. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
[TBL] [Abstract][Full Text] [Related]
15. 3D-QSAR Modeling and Synthesis of New Fusidic Acid Derivatives as Antiplasmodial Agents.
Kaur G; Pavadai E; Wittlin S; Chibale K
J Chem Inf Model; 2018 Aug; 58(8):1553-1560. PubMed ID: 30040885
[TBL] [Abstract][Full Text] [Related]
16. Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).
Pidathala C; Amewu R; Pacorel B; Nixon GL; Gibbons P; Hong WD; Leung SC; Berry NG; Sharma R; Stocks PA; Srivastava A; Shone AE; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Hill A; Fisher NE; Warman AJ; Biagini GA; Ward SA; O'Neill PM
J Med Chem; 2012 Mar; 55(5):1831-43. PubMed ID: 22364416
[TBL] [Abstract][Full Text] [Related]
17. In Silico Mining for Antimalarial Structure-Activity Knowledge and Discovery of Novel Antimalarial Curcuminoids.
Viira B; Gendron T; Lanfranchi DA; Cojean S; Horvath D; Marcou G; Varnek A; Maes L; Maran U; Loiseau PM; Davioud-Charvet E
Molecules; 2016 Jun; 21(7):. PubMed ID: 27367660
[TBL] [Abstract][Full Text] [Related]
18. An in silico 3D pharmacophore model of chalcones useful in the design of novel antimalarial agents.
Bhattacharjee AK; Nichols DA; Gerena L; Roncal N; Gutteridge CE
Med Chem; 2007 Jul; 3(4):317-26. PubMed ID: 17627568
[TBL] [Abstract][Full Text] [Related]
19. Application of molecular topology to the prediction of the antimalarial activity of a group of uracil-based acyclic and deoxyuridine compounds.
García-Domenech R; López-Peña W; Sanchez-Perdomo Y; Sanders JR; Sierra-Araujo MM; Zapata C; Gálvez J
Int J Pharm; 2008 Nov; 363(1-2):78-84. PubMed ID: 18675892
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel PfDHODH inhibitors as antimalarial agents via pharmacophore-based virtual screening followed by molecular docking and in vivo antimalarial activity.
Vyas VK; Qureshi G; Ghate M; Patel H; Dalai S
SAR QSAR Environ Res; 2016 Jun; 27(6):427-40. PubMed ID: 27310104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
